TCM
NTUS

Tekla Capital Management’s Natus Medical Inc NTUS Stock Holding History

Tekla Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-61,219
Closed -$1.57M – 205
2019
Q2 		$1.57M Buy
+61,219
New +$1.56M 0.06% 141
2018
Q2 		– Sell
-11,335
Closed -$381K – 193
2018
Q1 		$381K Buy
+11,335
New +$359K 0.01% 181

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Tekla Capital Management's NTUS Position: Q3 2019 in Review

Tekla Capital Management sold out of Natus Medical Inc (NTUS) in Q3 2019, closing a stake of 61,219 shares — an estimated $1.57M sold.

Tekla Capital Management first reported a position in NTUS in Q1 2018 and held it in 2 quarters. The position peaked at $1.57M in Q2 2019. 168 funds tracked by Wall St. Rank hold NTUS as of Q3 2019.

  • Tekla Capital Management reported no remaining Natus Medical Inc position as of Q3 2019 after selling out during the quarter.
  • Tekla Capital Management sold 61,219 Natus Medical Inc shares in Q3 2019, an estimated $1.57M.
  • Tekla Capital Management first reported a position in Natus Medical Inc in Q1 2018 and held it in 2 quarters.
  • Tekla Capital Management's Natus Medical Inc position peaked at $1.57M in Q2 2019.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2019.

Based on Tekla Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.